81586-0

NM Whole body Views W Y-90 ibritumomab tiuxetan IV

Active

LOINC Names Get Info

Fully-Specified Name: Views^W Y-90 ibritumomab tiuxetan IV:Find:Pt:Whole body:Doc:NM
Long Common Name: NM Whole body Views W Y-90 ibritumomab tiuxetan IV
Short Name: NM Whole body Views W Y-90 ibrit tiux IV

Part Model Get Info

Component
Views^W Y-90 ibritumomab tiuxetan IV
LP309799-7
- Analyte
  Views
  LP28726-5
  - Component Numerator
    Views
    LP28726-5
    - Component Numerator Core
      Views
      LP28726-5
    - Component Numerator Core Suffix
      NULL
  - Component Denominator
    NULL
    - Component Denominator Core
      NULL
    - Component Denominator Core Suffix
      NULL
- Challenge
  W Y-90 ibritumomab tiuxetan IV
  LP212084-0
- Adjustment
  NULL
- Count
  NULL
Property
Find
LP6813-2
Time
Pt
LP6960-1
- Time Core
  Pt
  LP6960-1
- Time Modifier
  NULL
System
Whole body
LP94547-4
- System Core
  Whole body
  LP94547-4
- Super System
  NULL
Scale
Doc
LP32888-7
Method
NM
LP208655-3

Associated Observations

81220-6 Diagnostic imaging report - recommended C-CDA R2.0 and R2.1 sections

This panel contains the recommended sections for diagnostic imaging reports based on HL7 Implementation Guide for CDA® Release 2: Consolidated CDA Templates for Clinical Notes (US Realm) DSTU Releases 2.0 & 2.1.

LOINC	Name	R/O/C
81220-6	Diagnostic imaging report - recommended C-CDA R2.0 and R2.1 sections
Indent11329-0	History general	O
Indent55115-0	Request (Radiology)	O
Indent55111-9	Current imaging procedure descriptions Document	O
Indent55114-3	Prior procedure descriptions	O
Indent18834-2	Radiology Comparison study - observation	O
Indent18782-3	Radiology Study observation (findings)	R
Indent19005-8	Radiology - Impression	O
Indent18783-1	Radiology Study recommendation	O
Indent55110-1	Conclusions	O
Indent55107-7	Addendum	O
Indent18785-6	Radiology Reason for study	O
Indent55108-5	Patient presentation	O
Indent55109-3	Complications	O
Indent55112-7	Summary	O
Indent55113-5	Key images	O

72230-6 Diagnostic imaging report - recommended C-CDA R1.1 sections

This panel contains the recommended sections for diagnostic imaging reports based on the HL7 Implementation Guide for CDA® Release 2: Consolidated CDA Templates for Clinical Notes (US Realm) DSTU Release 1.1.

LOINC	Name	R/O/C
72230-6	Diagnostic imaging report - recommended C-CDA R1.1 sections
Indent18782-3	Radiology Study observation (findings)	R
Indent55107-7	Addendum	O
Indent55108-5	Patient presentation	O
Indent55109-3	Complications	O
Indent55110-1	Conclusions	O
Indent55111-9	Current imaging procedure descriptions Document	O
Indent11329-0	History general	O
Indent55113-5	Key images	O
Indent55114-3	Prior procedure descriptions	O
Indent19005-8	Radiology - Impression	O
Indent18834-2	Radiology Comparison study - observation	O
Indent18785-6	Radiology Reason for study	O
Indent18783-1	Radiology Study recommendation	O
Indent55115-0	Request (Radiology)	O
Indent55112-7	Summary	O

Code System	Code	Code Text	Code Version
Radlex radiology codes. (Radiological Society of North America)	RPID5994	NM Whole Body Zevalin	RadLex Playbook 2.5

Basic Attributes

Class: RAD
Type: Clinical
First Released: Version 2.56
Last Updated: Version 2.64 (MIN)
Order vs. Observation: Both
HL7^® Attachment Structure: Implementation guide exists

Member of these Groups Get Info

LOINC Group	Group Name
LG41852-1	Region imaged: Whole body

Language Variants Get Info

Tag	Language	Translation
el-GR	Greek (Greece)	Λήψεις^Με Y-90 ιβριτουμομάμπη τιουξετάνη ενδοφλεβίως:Εύρεση:Pt:Ολόκληρο σώμα:Doc:NM Synonyms: Doc NM Pt RAD Εύρεση Λήψεις Με Y-90 ιβριτουμομάμπη τιουξετάνη ενδοφλεβίως Ολόκληρο σώμα
es-MX	Spanish (Mexico)	Vistas ^W Y-90 ibritumomab tiuxetan IV:Tipo:Punto temporal:Todo el cuerpo:Documento:NM
it-IT	Italian (Italy)	Viste^Con Y-90 ibritumomab tiuxetano IV:Osservazione:Pt:Corpo intero:Doc:NM Synonyms: Osservazione Punto nel tempo (episodio) Radiologia
zh-CN	Chinese (China)	多重视图^采用静脉注射 Y-90 替伊莫单抗:发现:时间点:全身:文档型:NM Synonyms: CD20 单克隆抗体 Films;View;Views;VWS;多张感光胶片;多张片;多张胶片;多片;多联片;多胶片;多重片;多重胶片 Ibritumomab tiuxetan Tiuxetan Zevalin 临床文档型;临床文档;文档;文书;医疗文书;临床医疗文书发现是一个原子型临床观察指标，并不是作为印象的概括陈述。体格检查、病史、系统检查及其他此类观察指标的属性均为发现。它们的标尺对于编码型发现可能是名义型，而对于叙述型文本之中所报告的发现，则可能是叙述型。;发现物;所见;结果;结论成像;放射医学;放射学;显像时刻;随机;随意;瞬间核医学方法;核医学设备;nuclear medicine 物体由单克隆抗体利妥昔单抗 Ibritumomab 与 MX-DTPA 螯合剂 Tiuxetan 经硫脲共价键结合而成躯干;全躯干;周身;周身上下;全身上下采用静脉注射 Y-90 替伊莫单抗;采用 Y-90 替伊莫单抗 IV;采用 Y-90 ibritumomab tiuxetan IV;采用静脉内注射 Y-90 替伊莫单抗（替依莫单抗、替依利莫单抗、ibritumomab tiuxetan）

LOINC Terminology Service (API) using HL7^® FHIR^® Get Info

CodeSystem lookup: https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=81586-0

LOINC Copyright

Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.